Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer.
D000818:Animals; D000873:Anthracenes / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D004558:Electric Stimulation; D005260:Female; D008376:Maprotiline / Q000031:analogs & derivatives / Q000494:pharmacology*; D008566:Membranes / Q000378:metabolism; D008968:Molecular Conformation; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D011224:Prazosin / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013237:Stereoisomerism; D013574:Synaptosomes / Q000378:metabolism; D014439:Tyramine / Q000031:analogs & derivatives / Q000494:pharmacology
D000873:Anthracenes; C001047:4, alpha-dimethyl-3-tyramine; D008376:Maprotiline; D012701:Serotonin; C027299:hydroxymaprotilin; D009638:Norepinephrine; D014439:Tyramine; D011224:Prazosin